Eligible AACR 2019 Annual Meeting Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

FDA 201: Topics in Oncology Regulation

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5
CBER, Microbiome, and CAR-T in Solid Tumors
Ke Liu
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
Non-proportional Hazards - Evolving Analytical Approaches
Rajeshwari Sridhara
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
External control arms
Pallavi Mishra-Kalyani
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
Minimal residual disease
Nicole J. Gormley
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
Bispecific T-cell Engager (BiTE) therapies
R. Angelo de Claro
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5